Toronto Dominion Bank’s Aptose Biosciences, Inc. APTO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-153
| Closed | -$12.9K | – | 1902 |
|
|
2023
Q3 | $12.9K | Buy |
+153
| New | +$18K | ﹤0.01% | 1282 |
|
|
2023
Q2 | – | Sell |
-108
| Closed | -$31K | – | 1912 |
|
|
2023
Q1 | $31K | Sell |
108
-18
| -14% | -$5.23K | ﹤0.01% | 1248 |
|
|
2022
Q4 | $32K | Buy |
126
+29
| +30% | +$7.79K | ﹤0.01% | 1344 |
|
|
2022
Q3 | $26K | Buy |
97
+43
| +80% | +$14.8K | ﹤0.01% | 1414 |
|
|
2022
Q2 | $18K | Sell |
54
-58
| -52% | -$27.7K | ﹤0.01% | 1189 |
|
|
2022
Q1 | $68K | Buy |
112
+49
| +78% | +$27.1K | ﹤0.01% | 1209 |
|
|
2021
Q4 | $38K | Buy |
63
+58
| +1,160% | +$54.5K | ﹤0.01% | 1373 |
|
|
2021
Q3 | $5K | Buy |
5
+4
| +400% | +$5K | ﹤0.01% | 1302 |
|
|
2021
Q2 | $1K | Hold |
1
| – | – | ﹤0.01% | 1351 |
|
|
2021
Q1 | $3K | Buy |
+1
| New | +$1.98K | ﹤0.01% | 1369 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 1465 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 1213 |
|
|
2020
Q1 | – | Sell |
-1
| Closed | -$3K | – | 1512 |
|
|
2019
Q4 | $3K | Buy |
+1
| New | +$1.3K | ﹤0.01% | 1267 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 1730 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 1817 |
|
|
2019
Q1 | – | Sell |
-1
| Closed | -$905 | – | 1787 |
|
|
2018
Q4 | $1K | Buy |
+1
| New | +$984 | ﹤0.01% | 1455 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 1624 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 1595 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 1454 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 1325 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 1305 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 1301 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 1327 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 1273 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 1324 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 1311 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 1114 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 1125 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 1157 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 1110 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 1080 |
|
Other funds holding APTO
DS
NCM
CC
SPC
AC
CA
TSS
TCBWMS
Toronto Dominion Bank's APTO Position: Q4 2023 in Review
Toronto Dominion Bank sold out of Aptose Biosciences, Inc. (APTO) in Q4 2023, closing a stake of 153 shares — an estimated $12.9K sold.
Toronto Dominion Bank first reported a position in APTO in Q4 2018 and held it in 12 quarters. The position peaked at $68K in Q1 2022. 25 funds tracked by Wall St. Rank hold APTO as of Q4 2023.
- Toronto Dominion Bank reported no remaining Aptose Biosciences, Inc. position as of Q4 2023 after selling out during the quarter.
- Toronto Dominion Bank sold 153 Aptose Biosciences, Inc. shares in Q4 2023, an estimated $12.9K.
- Toronto Dominion Bank first reported a position in Aptose Biosciences, Inc. in Q4 2018 and held it in 12 quarters.
- Toronto Dominion Bank's Aptose Biosciences, Inc. position peaked at $68K in Q1 2022.
- 25 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q4 2023.
Based on Toronto Dominion Bank's 13F filing for Q4 2023, filed 13 Feb 2024.